Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) were down 0.3% during mid-day trading on Thursday . The company traded as low as $97.77 and last traded at $97.77. Approximately 1,431 shares traded hands during trading, a decline of 80% from the average daily volume of 7,156 shares. The stock had previously closed at $98.05.
Analyst Upgrades and Downgrades
Separately, UBS Group upgraded CochLear from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 18th.
View Our Latest Research Report on CHEOY
CochLear Price Performance
The firm has a fifty day moving average of $90.79 and a 200 day moving average of $89.07.
CochLear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
